Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum

Zhenyu Guo Hongtian Li Yirui Ma Ying Meng Yubo Zhou Jianmeng Liu

Zhenyu Guo, Hongtian Li, Yirui Ma, Ying Meng, Yubo Zhou, Jianmeng Liu. Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum[J]. Biomedical and Environmental Sciences, 2025, 38(4): 459-468. doi: 10.3967/bes2024.155
Citation: Zhenyu Guo, Hongtian Li, Yirui Ma, Ying Meng, Yubo Zhou, Jianmeng Liu. Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum[J]. Biomedical and Environmental Sciences, 2025, 38(4): 459-468. doi: 10.3967/bes2024.155

doi: 10.3967/bes2024.155

Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum

Funds: This study was funded by the Clinical Medicine Plus X-Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities [2023]; and the Wyeth Nutrition Science Center [project number 14.10.CN.INF].
More Information
    Author Bio:

    Zhenyu Guo, Master, majoring in maternal and child epidemiology, E-mail: 2111210100@pku.edu.cn

    Corresponding author: Yubo Zhou, PhD, Associate Professor, E-mail: zhouyubo@bjmu.edu.cnJianmeng Liu, PhD, Professor, E-mail: liujm@pku.edu.cn
  • Study design and supervision: Jianmeng Liu, Yubo Zhou and Hongtian Li. Study design, data analysis, and manuscript drafting: Zhenyu Guo. Sample testing: Zhenyu Guo, Yirui Ma and Ying Meng. Jianmeng Liu and Yubo Zhou took responsibility for the integrity of the data and had full access to all of the data in the study. All authors have read and approved the final manuscript.
  • The authors declare that they have no conflict of interest.
  • The research protocol was reviewed and approved by the Institutional Review Board /Human Subjects Committee (IRB00001052-14012; date of approval: 22 April 2014). Informed consent was obtained from all participants before their enrollment.
    • 关键词:
    •  / 
    •  / 
    •  / 
    •  
    Study design and supervision: Jianmeng Liu, Yubo Zhou and Hongtian Li. Study design, data analysis, and manuscript drafting: Zhenyu Guo. Sample testing: Zhenyu Guo, Yirui Ma and Ying Meng. Jianmeng Liu and Yubo Zhou took responsibility for the integrity of the data and had full access to all of the data in the study. All authors have read and approved the final manuscript.
    The authors declare that they have no conflict of interest.
    The research protocol was reviewed and approved by the Institutional Review Board /Human Subjects Committee (IRB00001052-14012; date of approval: 22 April 2014). Informed consent was obtained from all participants before their enrollment.
    注释:
    1) Authors’ Contributions: 2) Competing Interests: 3) Ethics:
  • Figure  1.  Plasma Hcy concentrations in mid-pregnant, late pregnant, and postpartum women, by geographic regions in China. Data are presented as box plots; on each box, medians (central mark), interquartile range (bottom and top edges of the box), and minimum/maximum values (whiskers) are shown, n = 1,190.

    Table  1.   Characteristics of pregnant and postpartum women in China [n (%)]

    Characteristics Phases of pregnancy and postpartum P value
    Total
    (n = 1,190)
    Mid-pregnancy
    (n = 401)
    Late-pregnancy
    (n = 388)
    Postpartum
    (n = 401)
    Geographic region 0.943
    South 392 (32.9) 130 (32.4) 133 (34.3) 129 (32.2)
    Central 393 (33.0) 135 (33.7) 122 (31.4) 136 (33.9)
    North 405 (34.0) 136 (33.9) 133 (34.3) 136 (33.9)
    Age group (years) 0.243
    ≤ 25 328 (27.6) 122 (30.4) 106 (27.3) 100 (24.9)
    26–30 675 (56.7) 223 (55.6) 212 (54.6) 240 (59.9)
    > 30 187 (15.7) 56 (14.0) 70 (18.0) 61 (15.2)
    Pre-pregnancy BMI 0.325
    Underweight 223 (18.7) 73 (18.2) 73 (18.8) 77 (19.2)
    Normal weight 864 (72.6) 288 (71.8) 291 (75.0) 285 (71.1)
    Overweight/obese 103 (8.7) 40 (10.0) 24 (6.2) 39 (9.7)
    Parity 0.360
    Primiparous 992 (83.4) 337 (84.0) 315 (81.2) 340 (84.8)
    Multiparous 198 (16.6) 64 (16.0) 73 (18.8) 61 (15.2)
    Ethnicity 0.047
    Han 1,134 (95.3) 374 (93.3) 376 (96.9) 384 (95.8)
    Others 56 (4.7) 27 (6.7) 12 (3.1) 17 (4.2)
    Education 0.703
    Middle school or less 148 (12.4) 54 (13.5) 52 (13.4) 42 (10.5)
    High school 261 (21.9) 88 (21.9) 83 (21.4) 90 (22.4)
    College or higher 781 (65.6) 259 (64.6) 253 (65.2) 269 (67.1)
    Annual family income per capita (Yuan) < 0.001
    ≤ 30,000 609 (51.2) 184 (45.9) 164 (42.3) 261 (65.1)
    30,000 to < 50,000 324 (27.2) 122 (30.4) 103 (26.5) 99 (24.7)
    50,000 to < 100,000 225 (18.9) 85 (21.2) 104 (26.8) 36 (9.0)
    ≥ 100,000 32 (2.7) 10 (2.5) 17 (4.4) 5 (1.2)
    Postpartum women (n = 401)
    Delivery mode
    Vaginal delivery 239 (59.6)
    Cesarean delivery 162 (40.4)
    Breastfeed
    Partial breastfeeding 162 (40.4)
    Exclusive breastfeeding 239 (59.6)
      Note. BMI, body mass index. “–” denotes that the data were unavailable here.
    下载: 导出CSV

    Table  2.   The crude and adjusted plasma Hcy median (IQRs) concentrations (μmol/L) in pregnant and postpartum women in China

    Characteristics n (%) Overall women 
    (n = 1,190) 
    Pregnant women Postpartum women
    (n = 789) (n = 401)
    Crude
    concentrationa
    Adjusted
    concentrationb
    Adjusted
    concentration
    Adjusted
    concentration
    Phases of pregnancy and postpartum        
    Mid-pregnancy 401 (33.7) 4.68 (4.14, 5.51)1 4.75 (4.13, 5.54)1 4.74 (4.16, 5.56)1
    Late-pregnancy 388 (32.6) 5.75 (4.79, 7.12)2 5.72 (4.81, 6.85)2 5.76 (4.91, 6.96)2
    Postpartum 401 (33.7) 7.16 (5.69, 9.07)3 7.09 (5.65, 8.75)3 c
    Geographic region        
    South 392 (32.9) 5.47 (4.54, 7.10)1 5.61 (4.80, 6.81)1 4.96 (4.57, 5.89)1 6.48 (5.17, 8.90)1
    Central 393 (33.0) 5.52 (4.75, 6.64)1 5.56 (5.00, 6.60)1 4.88 (4.39, 5.49)1 7.13 (5.77, 8.19)2
    North 405 (34.0) 5.98 (4.47, 8.58)2 6.08 (4.70, 7.82)2 5.11 (4.26, 6.79)2 8.07 (6.26, 10.42)3
    Age group (years)        
    ≤ 25 328 (27.6) 5.79 (4.68, 7.76) 5.80 (5.07, 6.92)2 5.09 (4.52, 6.66)3 7.28 (6.37, 9.45)2
    26–30 675 (56.7) 5.61 (4.63, 7.23) 5.63 (4.80, 6.80)1 4.88 (4.33, 6.49)2 7.13 (5.66, 8.88)1
    > 30 187 (15.7) 5.46 (4.45, 7.48) 5.83 (4.63, 7.67)1 5.45 (4.45, 6.25)1 7.41 (5.70, 10.13)
    Pre-pregnancy BMI        
    Underweight 223 (18.7) 5.89 (4.67, 7.53) 5.82 (4.95, 6.91)2 5.13 (4.57, 6.60)3 7.22 (5.91, 9.67)1
    Normal weight 864 (72.6) 5.60 (4.62, 7.23) 5.67 (4.80, 6.80)1 4.97 (4.46, 6.49)2 7.13 (5.66, 8.90)1
    Overweight/obesity 103 (8.7) 5.66 (4.53, 8.10) 6.01 (4.77, 7.90) 4.64 (4.15, 6.22)1 8.20 (6.60, 9.89)2
    Parity        
    Primiparous 992 (83.4) 5.66 (4.65, 7.23) 5.68 (4.88, 6.78) 4.98 (4.44, 6.49) 7.13 (5.73, 8.88)1
    Multiparous 198 (16.6) 5.70 (4.50, 7.87) 5.92 (4.72, 7.33) 5.53 (4.45, 6.55) 7.52 (5.83, 10.85)2
    Ethnicity        
    Han 1,134 (95.3) 5.67 (4.63, 7.41) 5.74 (4.81, 6.90)2 5.07 (4.45, 6.50)2 7.15 (5.72, 9.18)
    Other 56 (4.7) 5.39 (4.39, 6.97) 5.07 (4.77, 6.48)1 4.70 (4.11, 5.81)1 7.05 (6.43, 9.68)
    Education        
    Middle school or less 148 (12.4) 5.55 (4.63, 7.06) 5.66 (4.90, 7.06)1 5.11 (4.53, 6.31) 7.34 (5.78, 11.13)
    High school 261 (21.9) 5.72 (4.66, 7.84) 5.82 (5.00, 6.96)2 4.98 (4.52, 6.68) 7.24 (5.83, 9.28)
    College or higher 781 (65.6) 5.66 (4.57, 7.25) 5.68 (4.78, 6.79)1 4.98 (4.36, 6.49) 7.13 (5.72, 8.90)
    Annual family income per capita (Yuan)        
    ≤ 30,000 609 (51.2) 5.86 (4.67, 7.98)2 6.03 (4.99, 7.82)3 4.97 (4.39, 6.59)2 7.15 (5.70, 9.58)2
    30,000 to < 50,000 324 (27.2) 5.63 (4.68, 7.02)1 5.63 (4.93, 6.63)2 4.97 (4.49, 6.40)2 7.26 (6.13, 8.83)2
    50,000 to < 100,000 225 (18.9) 5.33 (4.48, 6.43)1 5.45 (4.60, 6.60)1 5.56 (4.67, 6.44)3 6.07 (5.34, 8.74)1
    ≥ 100,000 32 (2.7) 4.91 (4.39, 6.06)1 5.15 (4.53, 5.48)1 4.87 (4.34, 5.67)1 7.88 (7.28, 9.16)2
    Delivery mode        
    Vaginal delivery 7.15 (5.83, 8.90)2
    Caesarean delivery 6.81 (5.70, 9.59)1
    Feeding practice  
    Partial breastfeeding 7.24 (5.72, 9.41)2
    Exclusive breastfeeding 6.76 (5.82, 8.96)1
      Note. BMI, body mass index; IQR, interquartile range. aThe crude or adjusted median Hcy concentrations were compared through Mann-Whitney U test or Kruskal-Wallis test followed by Dwass-Steel-Crichtlow-Fligner test for multiple comparisons. The different numerical superscripts indicate significant differences in medians (1 < 2 < 3), P < 0.05. bThe adjusted medians (IQRs) were estimated by multivariate quantile regression model, which adjusted for phases of pregnancy and postpartum, geographic region, maternal age, pre-pregnancy BMI, parity, educational level, ethnicity, educational level and average annual family income; delivery mode and feeding practice were further included in models for postpartum women. c“–” denotes that the data were unavailable here.
    下载: 导出CSV

    Table  3.   Association of hyperhomocysteinemia with characteristics of pregnant and postpartum women in China

    Characteristics Case of
    hyperhomocysteinemia
    Overall women Pregnant women Postpartum women
    n (%) Crude OR
    (95% CI)
    Adjusted OR
    (95% CI)a
    Adjusted OR
    (95% CI)a
    Adjusted OR
    (95% CI)a
    Phases of pregnancy and postpartum    
    Mid-pregnancy 7 (1.7) Ref Ref b
    Late-pregnancy 33 (8.5) 5.23 (2.29–11.97) 5.09 (2.18–11.86)
    Postpartum 66 (16.5) 11.09 (5.02–24.49) 12.11 (5.39–27.21)
    Geographic region
    South 34 (8.7) Ref Ref Ref Ref
    Central 7 (1.8) 0.19 (0.08–0.44) 0.18 (0.08–0.44) 0.31 (0.08–1.19) 0.12 (0.04–0.38)
    North 65 (16.0) 2.01 (1.30–3.13) 2.30 (1.42–3.72) 2.69 (1.24–5.83) 2.55 (1.33–4.90)
    Age group (years)
    ≤ 25 30 (9.1) 1.18 (0.74–1.89) 0.98 (0.57–1.69) 0.95 (0.42–2.15) 0.84 (0.40–1.77)
    26–30 53 (7.9) Ref Ref Ref Ref
    > 30 23 (12.3) 1.65 (0.98–2.76) 1.15 (0.63–2.09) 1.20 (0.49–2.95) 1.30 (0.57–2.96)
    Pre-pregnancy BMI
    Underweight 18 (8.1) 0.88 (0.52–1.51) 0.75 (0.42–1.32) 0.77 (0.30–1.93) 0.75 (0.36–1.56)
    Normal weight 78 (9.0) Ref Ref Ref Ref
    Overweight/obesity 10 (9.7) 1.08 (0.54–2.17) 1.02 (0.47–2.21) 0.68 (0.19–2.36) 1.18 (0.42–3.30)
    Parity
    Primiparous 74 (7.5) Ref Ref Ref Ref
    Multiparous 32 (16.2) 2.39 (1.53–3.74) 1.68 (0.94–3.00) 1.50 (0.63–3.59) 1.93 (0.88–4.25)
    Ethnicity
    Han 101 (8.9) Ref Ref Ref Ref
    Other 5 (8.9) 1.00 (0.39–2.57) 0.89 (0.32–2.46) 0.96 (0.27–3.39) 0.59 (0.12–2.96)
    Education
    Middle school or less 21 (14.2) Ref Ref Ref Ref
    High school 26 (10.0) 0.67 (0.36–1.24) 0.77 (0.38–1.53) 0.95 (0.34–2.63) 0.57 (0.21–1.50)
    College or higher 59 (7.6) 0.49 (0.29–0.84) 0.54 (0.28–1.04) 0.64 (0.25–1.65) 0.39 (0.15–1.02)
    Annual family income per capita (Yuan)
    ≤ 30,000 72 (11.8) Ref Ref Ref Ref
    30,000 to < 50,000 22 (6.8) 0.54 (0.33–0.89) 0.70 (0.41–1.19) 0.82 (0.37–1.79) 0.59 (0.28–1.24)
    50,000 to < 100,000 11 (4.9) 0.38 (0.20–0.74) 0.53 (0.26–1.08) 0.49 (0.18–1.34) 0.68 (0.25–1.85)
    ≥ 100,000 1 (3.1) 0.24 (0.03–1.79) 0.35 (0.04–2.74) 0.66 (0.08–5.33) ×c
    Delivery mode
    Vaginal delivery Ref
    Caesarean delivery 0.70 (0.38–1.30)
    Feeding Practice
    Partial breastfeeding Ref
    Exclusive breastfeeding 1.32 (0.71–2.45)
      Note. 95% CI, 95% confidence interval; OR, odds ratio; Ref, reference; BMI, body mass index. aAdjusted ORs and 95% CIs were estimated by multivariable logistic regression models by including phases of pregnancy and postpartum, geographic region, maternal age, pre–pregnancy BMI, parity, ethnicity, education level and income; delivery mode and feeding practice were further included in models for postpartum women. b“–” denotes that the data were unavailable here. c“×” denotes that it was not applicable since no case of hyperhomocysteinemia in this subgroup of postpartum women.
    下载: 导出CSV

    S1.   Association of hyperhomocysteinemia (defined as > 15.0 μmol/L) with characteristics of pregnant and postpartum women in China

    Characteristics Case of hyperhomocysteinemia
    (Defined as > 15.0 μmol/L)
    Overall women
    n (%) Crude OR (95% CI) Adjusted OR (95% CI)a
    Phases of pregnancy and postpartum  
    Mid–pregnancy 4 (1.0) Ref Ref
    Late–pregnancy 6 (1.5) 1.56 (0.44–5.57) 1.28 (0.35–4.74)
    Postpartum 25 (6.2) 6.60 (2.28–19.14) 6.46 (2.17–19.18)
    Geographic region
    South 8 (2.0) Ref Ref
    Central 2 (0.5) 0.25 (0.05–1.16) 0.22 (0.04–1.11)
    North 25 (6.2) 3.16 (1.41–7.09) 3.56 (1.52–8.38)
    Age group
    ≤ 25 11 (3.4) 1.64 (0.74–3.65) 1.42 (0.58–3.49)
    26–30 14 (2.1) Ref Ref
    > 30 10 (5.3) 2.67 (1.17–6.11) 2.17 (0.86–5.48)
    Pre-pregnancy BMI
    Underweight 6 (2.7) 1.01 (0.41–2.51) 0.84 (0.32–2.20)
    Normal weight 23 (2.7) Ref Ref
    Overweight/obesity 6 (5.8) 2.26 (0.90–5.69) 1.95 (0.71–5.34)
    Parity
    Primiparous 24 (2.4) Ref Ref
    Multiparous 11 (5.6) 2.37 (1.14–4.93) 1.60 (0.62–4.12)
    Ethnicity
    Han 35 (3.1) Ref Ref
    Other 0 (0.0) b b
    Education
    Middle school or less 7 (4.7) Ref Ref
    High school 9 (3.4) 0.67 (0.36–1.24) 0.81 (0.26–2.49)
    College or higher 19 (2.4) 0.50 (0.21–1.22) 0.61 (0.21–1.79)
    Annual family income per capita (Yuan)
    ≤ 30,000 24 (3.9) Ref Ref
    30,000 to < 50,000 9 (2.8) 0.70 (0.32–1.52) 0.88 (0.38–2.03)
    50,000 to < 100,000 2 (0.9) 0.22 (0.05–0.93) 0.37 (0.08–1.64)
    ≥ 100,000 0 (0.0) ×c ×c
      Note. 95% CI, 95% confidence interval; BMI, body mass index; OR, odds ratio; Ref, reference. aAdjusted ORs and 95% CIs were estimated by multivariable logistic regression models by including phases of pregnancy and postpartum, geographic region, maternal age, pre-pregnancy BMI, parity, ethnicity, education level and income; delivery mode and feeding practice were further included in models for postpartum women. b“–” denotes that the data were unavailable here. c“×” denotes that it was not applicable since no case of hyperhomocysteinemia in the specific groups.
    下载: 导出CSV
  • [1] Mudd SH. Vascular disease and homocysteine metabolism. N Engl J Med, 1985; 313, 751−3. doi:  10.1056/NEJM198509193131210
    [2] Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation, 2015; 132, e6−9.
    [3] Pietrzik K, Brönstrup A. Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population. Eur J Pediatr, 1998; 157 Suppl 2, S135-8.
    [4] Jan M, Cueto R, Jiang X, et al. Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells. Redox Biol, 2021; 45, 102018. doi:  10.1016/j.redox.2021.102018
    [5] Guéant JL, Guéant-Rodriguez RM, Oussalah A, et al. Hyperhomocysteinemia in cardiovascular diseases: revisiting observational studies and clinical trials. Thromb Haemost, 2023; 123, 270−82. doi:  10.1055/a-1952-1946
    [6] Serrano NC, Quintero-Lesmes DC, Becerra-Bayona S, et al. Association of pre-eclampsia risk with maternal levels of folate, homocysteine and vitamin B12 in Colombia: a case-control study. PLoS One, 2018; 13, e0208137. doi:  10.1371/journal.pone.0208137
    [7] Chaudhry SH, Taljaard M, MacFarlane AJ, et al. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort. BMC Pregnancy Childbirth, 2019; 19, 75. doi:  10.1186/s12884-019-2219-5
    [8] Gu YH, Zhang Q, Guo J, et al. Higher serum homocysteine and lower thyroid hormone levels in pregnant women are associated with neural tube defects. J Trace Elem Med Biol, 2021; 68, 126814. doi:  10.1016/j.jtemb.2021.126814
    [9] Rubini E, Snoek KM, Schoenmakers S, et al. First trimester maternal homocysteine and embryonic and fetal growth: the Rotterdam periconception cohort. Nutrients, 2022; 14, 1129. doi:  10.3390/nu14061129
    [10] Aishwarya S, Rajendiren S, Kattimani S, et al. Homocysteine and serotonin: association with postpartum depression. Asian J Psychiatr, 2013; 6, 473−7. doi:  10.1016/j.ajp.2013.05.007
    [11] Walker MC, Smith GN, Perkins SL, et al. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol, 1999; 180, 660−4. doi:  10.1016/S0002-9378(99)70269-3
    [12] Murphy MM, Scott JM, McPartlin JM, et al. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr, 2002; 76, 614−9. doi:  10.1093/ajcn/76.3.614
    [13] Choi R, Choi S, Lim Y, et al. A prospective study on serum methylmalonic acid and homocysteine in pregnant women. Nutrients, 2016; 8, 797. doi:  10.3390/nu8120797
    [14] Bondevik GT, Schneede J, Refsum H, et al. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr, 2001; 55, 856−64.
    [15] Milman N, Bergholt T, Byg KE, et al. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol, 2007; 79, 39−46. doi:  10.1111/j.1600-0609.2007.00873.x
    [16] Batalha MA, dos Reis Costa PN, Ferreira ALL, et al. Maternal mental health in late pregnancy and longitudinal changes in postpartum serum vitamin B-12, homocysteine, and milk B-12 concentration among Brazilian women. Front Nutr, 2022; 9, 923569. doi:  10.3389/fnut.2022.923569
    [17] Wallace JM, Bonham MP, Strain J, et al. Homocysteine concentration, related B vitamins, and betaine in pregnant women recruited to the Seychelles Child Development Study. Am J Clin Nutr, 2008; 87, 391−7. doi:  10.1093/ajcn/87.2.391
    [18] Midttun Ø, Theofylaktopoulou D, McCann A, et al. Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations. Am J Clin Nutr, 2017; 105, 1314−26. doi:  10.3945/ajcn.116.151241
    [19] Binia A, Contreras AV, Canizales-Quinteros S, et al. Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism. Genes Nutr, 2014; 9, 421. doi:  10.1007/s12263-014-0421-7
    [20] Li Y, Li HT, Trasande L, et al. DHA in pregnant and lactating women from coastland, Lakeland, and inland areas of China: results of a DHA evaluation in women (DEW) study. Nutrients, 2015; 7, 8723−32. doi:  10.3390/nu7105428
    [21] Zhou YB, Li HT, Trasande L, et al. A correlation study of DHA intake estimated by a FFQ and concentrations in plasma and erythrocytes in mid- and late pregnancy. Nutrients, 2017; 9, 1256. doi:  10.3390/nu9111256
    [22] Sawuła W, Banecka-Majkutewicz Z, Kadziński L, et al. Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochim Pol, 2008; 55, 119−25. doi:  10.18388/abp.2008_3161
    [23] Paprotny Ł, Wianowska D, Izdebska M, et al. Analysis of serum homocysteine in the laboratory practice - comparison of the direct chemiluminescence immunoassay and high performance liquid chromatography coupled with fluorescent detection. Biochem Med (Zagreb), 2020; 30, 030703.
    [24] Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem, 2004; 50, 3−32. doi:  10.1373/clinchem.2003.021634
    [25] Takimoto H, Mito N, Umegaki K, et al. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. Eur J Nutr, 2007; 46, 300−6. doi:  10.1007/s00394-007-0667-6
    [26] Yang YQ, Jiang HM, Tang AG, et al. Changes of serum homocysteine levels during pregnancy and the establishment of reference intervals in pregnant Chinese women. Clin Chim Acta, 2019; 489, 1−4. doi:  10.1016/j.cca.2018.11.026
    [27] Bianchi V, Lanati A, Martino F, et al. Comparison of five different plasma homocysteine assays in routine analysis. Clin Chim Acta, 2012; 413, 1768−9. doi:  10.1016/j.cca.2012.06.027
    [28] Zhou YB, Si KY, Li HT, et al. Trends and influencing factors of plasma folate levels in Chinese women at mid-pregnancy, late pregnancy and lactation periods. Br J Nutr, 2021; 126, 885−91. doi:  10.1017/S0007114520004821
    [29] Tchantchou F. Homocysteine metabolism and various consequences of folate deficiency. J Alzheimers Dis, 2006; 9, 421−7. doi:  10.3233/JAD-2006-9408
    [30] Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993; 270, 2693−8. doi:  10.1001/jama.1993.03510220049033
    [31] Molloy AM, Mills JL, McPartlin J, et al. Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5, 10-methylenetetrahydrofolate reductase 677C→T variant. Am J Obstet Gynecol, 2002; 186, 499−503. doi:  10.1067/mob.2002.121105
    [32] Chaudhry SH, Taljaard M, MacFarlane AJ, et al. The determinants of maternal homocysteine in pregnancy: findings from the Ottawa and Kingston Birth Cohort. Public Health Nutr, 2020; 23, 3170−80. doi:  10.1017/S1368980019004002
    [33] Wouters MGAJ, Moorrees MTEC, van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest, 1995; 25, 801−5. doi:  10.1111/j.1365-2362.1995.tb01687.x
    [34] Dimitrova KR, DeGroot K, Myers AK, et al. Estrogen and homocysteine. Cardiovasc Res, 2002; 53, 577−88. doi:  10.1016/S0008-6363(01)00462-X
    [35] Yang BY, Fan SJ, Zhi XY, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients, 2014; 7, 74−90. doi:  10.3390/nu7010074
    [36] Zhao YL, Hao L, Zhang L, et al. Plasma folate status and dietary folate intake among Chinese women of childbearing age. Matern Child Nutr, 2009; 5, 104−16. doi:  10.1111/j.1740-8709.2008.00172.x
    [37] Crider KS, Zhu JH, Hao L, et al. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr, 2011; 93, 1365−72. doi:  10.3945/ajcn.110.004671
    [38] Lin JJ, Cao SY, Wu Y, et al. Genetic polymorphisms in folate metabolism as risk for Down syndrome in the southern China. J Matern Fetal Neonatal Med, 2019; 32, 2030−5. doi:  10.1080/14767058.2018.1424818
    [39] Long S, Goldblatt J. MTHFR genetic testing: controversy and clinical implications. Aust Fam Physician, 2016; 45, 237−40.
    [40] Bergen NE, Jaddoe VWV, Timmermans S, et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG, 2012; 119, 739−51. doi:  10.1111/j.1471-0528.2012.03321.x
    [41] Powers HJ, Moat SJ. Developments in the measurement of plasma total homocysteine. Curr Opin Clin Nutr Metab Care, 2000; 3, 391−7. doi:  10.1097/00075197-200009000-00011
    [42] Rasmussen K, Møller J. Total homocysteine measurement in clinical practice. Ann Clin Biochem, 2000; 37, 627−48. doi:  10.1258/0004563001899915
  • [1] Liang Zhang, Qian Han, Meiru Bao, Ying Wu.  Impact of Endometrial Polyps on Pregnancy Outcomes in Patients with Endometriosis and Infertility: A Systematic Review and Meta-analysis . Biomedical and Environmental Sciences, 2025, 38(3): 341-350. doi: 10.3967/bes2024.175
    [2] SHAN Xiao Yun, ZOU Yan, HUANG Li Chun, JIANG Shan, ZHOU Wei Wen, QIN Qiu Lan, LIU Chang Qing, LUO Xiao Yan, LU Jia Xi, MAO De Qian, LI Min, YANG Zhen Yu, YANG Li Chen.  Iodine Nutrition, Thyroid-stimulating Hormone, and Related Factors of Postpartum Women from three Different Areas in China: A Cross-sectional Survey . Biomedical and Environmental Sciences, 2024, 37(3): 254-265. doi: 10.3967/bes2024.029
    [3] WANG Shu Lei, SUN Meng Yun, HUANG Xing, ZHANG Da Ming, YANG Li, XU Tao, PAN Xiao Ping, ZHENG Rui Min.  Benefits of Mindfulness Training on the Mental Health of Women During Pregnancy and Early Motherhood: A Randomized Controlled Trial . Biomedical and Environmental Sciences, 2023, 36(4): 353-366. doi: 10.3967/bes2023.041
    [4] MI Xin, LIN Shi Qi, ZHANG Xiao Fen, LI Jia Jia, PEI Li Jun, JIN Feng, LIAO Qi, XIE Li Min, WEI Li Cong, HAO Chan Juan, ZHANG Ya Wei, LI Wei.  Maternal Perfluorinated Compound Exposure and Risk of Early Pregnancy Loss: A Nested Case-control Study . Biomedical and Environmental Sciences, 2022, 35(2): 174-179. doi: 10.3967/bes2022.026
    [5] Standard of Recommendation for Weight Gain during Pregnancy Period . Biomedical and Environmental Sciences, 2022, 35(10): 875-877. doi: 10.3967/bes2022.114
    [6] XI Jun Yan, CHEN Yuan Yuan, ZHANG Yu Qin, LUO Ao, DU Zhi Cheng, LIANG Bo Heng, DONG Hang, LIN Xiao, QIN Peng Zhe, HAO Yuan Tao.  Key Social Determinants to Narrow the Gap between Health-adjusted Life Expectancy and Life Expectancy in Megacities . Biomedical and Environmental Sciences, 2022, 35(9): 773-781. doi: 10.3967/bes2022.102
    [7] GAI Xiao Yan, CHI Hong Bin, ZENG Lin, CAO Wen Li, CHEN Li Xue, ZHANG Chen, LU Ming, NING Lan Ding, CHANG Chun, ZHANG Wei Xia, LIU Ping, LI Rong, SUN Yong Chang, QIAO Jie.  Untreated Prior Pulmonary Tuberculosis Adversely Affects Pregnancy Outcomes in Infertile Women Undergoing in vitro Fertilization and Embryo Transfer: A Large Retrospective Cohort Study . Biomedical and Environmental Sciences, 2021, 34(2): 130-138. doi: 10.3967/bes2021.019
    [8] LIU Yi Qun, HUANG Ling He, LIU Pei Pei, XING Qing Bin, HAN Feng, WANG Qin, CHEN Shu Rong, SUGIYAMA Kimio, XIANG Xue Song, HUANG Zhen Wu.  Effect of N,N-Dimethylglycine on Homocysteine Metabolism in Rats Fed Folate-Sufficient and Folate-Deficient Diets . Biomedical and Environmental Sciences, 2021, 34(5): 356-363. doi: 10.3967/bes2021.047
    [9] CHEN Xue Yu, YANG Yao, TANG Zhao Yang, LYU Jian, SHI Feng Xue, CHEN Yan Ru, WANG Xiao Hui, TAN Tan, XING Wei Jia, HOU Hai Feng, JI Long, LI Xiao Dong, LI Dong.  Association between Hypertension with Hyperhomocysteinemia and Cognitive Impairment in the Kailuan Community of China: A Cross-sectional Study . Biomedical and Environmental Sciences, 2021, 34(7): 557-561. doi: 10.3967/bes2021.076
    [10] CAO Lu Jia, LIN Hong Yan, LIANG Xuan, CHEN Yong Jie, LIU Yu Yan, ZHENG Yu Zhi, WANG Xin Yan, LI Wen, YAN Jing, HUANG Guo Wei.  Association between Pre-pregnancy Body Mass Index and Offspring Neuropsychological Development from 1 to 24 Months of Age: A Birth Cohort Study in China . Biomedical and Environmental Sciences, 2019, 32(10): 730-738. doi: 10.3967/bes2019.093
    [11] HU Fang, LIANG Jing Jing, LU Jian Jun, HU Yi Fei, HU Yan, YU Jia, ZOU Xing Wen, MA Ying Hua, LIN Sui Fang.  Effects of Antiretroviral Therapy and HIV Exposure in Utero on Adverse Pregnancy and Infant Outcomes: A Prospective Cohort Study in Guangzhou, China . Biomedical and Environmental Sciences, 2019, 32(10): 719-729. doi: 10.3967/bes2019.092
    [12] WANG Yu Heng, YAN Qing Hua, XU Ji Ying, LI Xin Jian, CHENG Min Na.  High Prevalence and Factors Contributing to Hyperhomocysteinemia, Folate Deficiency, and Vitamin B12 Deficiency among Healthy Adults in Shanghai, China . Biomedical and Environmental Sciences, 2019, 32(1): 63-67. doi: 10.3967/bes2019.010
    [13] DU Hong Yi, JIANG Hong, O Karmin, CHEN Bo, XU Lin Ji, LIU Shu Ping, YI Jian Ping, HE Geng Sheng, QIAN Xu.  Association of Dietary Pattern during Pregnancy and Gestational Diabetes Mellitus: A Prospective Cohort Study in Northern China . Biomedical and Environmental Sciences, 2017, 30(12): 887-897. doi: 10.3967/bes2017.119
    [14] YANG Fang, WANG Hua, SHI Jing Cheng, HU Ming.  Validity of Different Methods to Prenatal Screening for Down's Syndrom During First and Second Trimester Pregnancy of Chinese Women . Biomedical and Environmental Sciences, 2013, 26(2): 87-93. doi: 10.3967/0895-3988.2013.02.002
    [15] ZHANG Dong Mei, HU Zhi, ORTON Sophie, WANG Jia Ji, ZHENG Jian Zhong, QIN Xia, CHEN Ruo Ling.  Socio-economic and Psychosocial Determinants of Smoking and Passive Smoking in Older Adults . Biomedical and Environmental Sciences, 2013, 26(6): 453-467. doi: 10.3967/0895-3988.2013.06.006
    [16] HU Ying, CHEN ErJun, MU Yue, LI JinLu, CHEN RenJi.  BHMT Gene Polymorphisms as Risk Factors for Cleft Lip and Cleft Palate in a Chinese Population . Biomedical and Environmental Sciences, 2011, 24(2): 89-93. doi: 10.3967/0895-3988.2011.02.001
    [17] LING WANG, JIE LI, YAN XIE, XUE-GUANG ZHANG.  Association between Serum Homocysteine and Oxidative Stress in Elderly Patients with Obstructive Sleep Apnea/hypopnea Syndrome1 . Biomedical and Environmental Sciences, 2010, 23(1): 42-47.
    [18] LEI HUANG, XIAO-MING SONG, WEN-LI ZHU, YONG LI.  Plasma Homocysteine and Gene Polymorphisms Associated with the Risk of Hyperlipidemia in Northern Chinese Subjects . Biomedical and Environmental Sciences, 2008, 21(6): 514-520.
    [19] JUN-FU ZHOU, XIN-YU WANG, XUE-JUN SHANGGUAN, ZU-MING GAO, SHU-MEI ZHANG, WEI-QIANG XIAO, CHANG-GUI CHEN.  Increased Oxidative Stress in Women With Pregnancy-induced Hypertension . Biomedical and Environmental Sciences, 2005, 18(6): 419-426.
    [20] JUN CHENG, WEN-LI ZHU, JING-JING DAO, SHU-QING LI, YONG LI.  Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect . Biomedical and Environmental Sciences, 2005, 18(1): 58-64.
  • 加载中
图(1) / 表ll (4)
计量
  • 文章访问数:  134
  • HTML全文浏览量:  49
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-03-27
  • 录用日期:  2024-08-26
  • 网络出版日期:  2025-04-30
  • 刊出日期:  2025-04-30

Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum

doi: 10.3967/bes2024.155
    基金项目:  This study was funded by the Clinical Medicine Plus X-Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities [2023]; and the Wyeth Nutrition Science Center [project number 14.10.CN.INF].
    作者简介:

    Zhenyu Guo, Master, majoring in maternal and child epidemiology, E-mail: 2111210100@pku.edu.cn

    通讯作者: Yubo Zhou, PhD, Associate Professor, E-mail: zhouyubo@bjmu.edu.cnJianmeng Liu, PhD, Professor, E-mail: liujm@pku.edu.cn
注释:
1) Authors’ Contributions: 2) Competing Interests: 3) Ethics:

English Abstract

Zhenyu Guo, Hongtian Li, Yirui Ma, Ying Meng, Yubo Zhou, Jianmeng Liu. Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum[J]. Biomedical and Environmental Sciences, 2025, 38(4): 459-468. doi: 10.3967/bes2024.155
Citation: Zhenyu Guo, Hongtian Li, Yirui Ma, Ying Meng, Yubo Zhou, Jianmeng Liu. Homocysteine Levels and Determinants among Chinese Women at Mid-pregnancy, Late Pregnancy, and Postpartum[J]. Biomedical and Environmental Sciences, 2025, 38(4): 459-468. doi: 10.3967/bes2024.155
    • Homocysteine (Hcy) is a non-protein amino acid produced by the demethylation of methionine[1]. Elevated plasma Hcy levels or hyperhomocysteinemia, can result from either mutation genes coding for enzymes of Hcy metabolism[2], or deficiencies of B vitamins[3]. Hyperhomocysteinemia might lead to thrombosis, endothelial injury[4] and even cardiovascular disease[5]. Hyperhomocysteinemia in pregnant and postpartum women might be detrimental to maternal and offspring health, possibly related to compromised maternal vascular function. In pregnant women, hyperhomocysteinemia has been reported to be associated with increased risks of preeclampsia[6], placental abruption[7], neural tube defects[8], and low birth weight[9]; and in postpartum women, it was associated with postpartum depression[10]. Given these adverse effects, it is essential to comprehensively investigate the Hcy levels in women during pregnancy and postpartum.

      Previous studies have shown a considerable fluctuation of Hcy levels from pre-pregnancy to mid-pregnancy women[11-14]. However, only three studies, conducted in as early as 1990s, have reported maternal Hcy levels for late-pregnant and postpartum women[15-17]. Given the increasing popularity of B-vitamin supplementation during pregnancy in the past decades, updated data on Hcy levels in pregnant and postpartum women are needed. Additionally, the aforementioned studies were conducted in non-Asian populations (Danish, Brazilian and Seychellois), whereas related data from Asian population are lacking. Compared with western populations, Asian population generally possess relatively lower levels of B vitamins such as folate and B12[18] and distinct gene polymorphisms of the Hcy metabolism[19], suggesting that data from western countries might not be applicable to Asian populations. Therefore, it is necessary to explore the current Hcy status in pregnant and postpartum Asian women.

      Using data from a cross-sectional study among women residing in southern, central and northern regions of China, we aimed to assess the Hcy levels in mid-pregnancy, late-pregnancy and postpartum women, and to explore the potential determinants such as geographic region and maternal age.

    • This cross-sectional study was carried out between May and July 2014 with the primary aim of evaluating docosahexaenoic acid (DHA) status among pregnant and lactating women in China. As detailed in elsewhere[20,21], women at mid-pregnancy, late pregnancy, and postpartum were equally recruited in three cities of China: Yueyang, Weihai, and Baotou. Yueyang, a city located in latitude of 29°37′ N, represents southern region of China; Weihai, a city located in a latitude of 37°25′N, represents central region; Baotou, a city located in latitude of 40°15′ N, represents northern region.

      The participants were recruited at local maternal and child health centers during their routine prenatal or postpartum clinic visits. Women at mid-pregnancy were enrolled during 15–19 gestational weeks, women at late-pregnancy were enrolled during 37–41 gestational weeks, and women at postpartum were enrolled at 42 ± 7 days postpartum. Healthy women aged 18 to 35 years who had a singleton pregnancy or delivered a single healthy neonate were included in this study. For postpartum women, only those exclusive or partial breastfeeding their infants were included. Among 1,254 women initially enrolled, 23 were excluded for age > 35 years, 20 for not being in the predetermined gestational weeks or postpartum days, and 21 for having no sufficient blood samples. Finally, 1,190 women were remained in the present study.

    • Information on maternal socio-demographic characteristics including maternal age, ethnicity, education status, annual family income per capita, height and weight before pregnancy, parity, and gestational age at enrollment or delivery was collected by trained obstetricians or nurses using a structured questionnaire. Pre-pregnancy weight in kilograms and the height in meters was used to calculate the pre-pregnancy body mass index (BMI), which was categorized as follows: < 18.5 kg/m2 (underweight), 18.5 to < 25 kg/m2 (normal weight), and ≥ 25 kg/m2 (overweight/obesity). Information about delivery mode and feeding practice was additionally collected for postpartum women.

      About 5 mL of fasting venous blood was collected from each woman into ethylenediaminetetraacetic acid (EDTA)-containing tubes. The blood samples were then kept at 4 °C until they were processed for plasma aliquots within 4 hours. The plasma aliquots were stored at −20 °C at local hospitals for about 10 days, and then transported on dry ice to the National Health Commission Key Laboratory of Reproductive Health at Peking University Health Science Center in China, and stored at −80 °C until analysis.

    • Plasma Hcy concentration was analyzed by high-performance liquid chromatography (HPLC, Waters Alliance 2690) with a fluorescence detector (Waters Alliance 2475)[22], a preferential method for analyzing Hcy[23]. In brief, 10 μL of an internal standard, N-Acety-L-Cysteine (NAC) was added to 90 μL plasma. Then, 10 μL of 10% trichloroethyl phosphate (TCEP), was added to each sample, followed by incubation at 4 °C for 30 minutes. Subsequently, 100 µL of 10% trichloroacetic acid (TCAA) containing 1 mmol/L ethylene diamine tetraacetic acid (EDTA) was added and the mixture was centrifuged for 6 min at 15,000 ×g. 100 μL clear supernatant was extracted and transferred to a new tube. Then, after adding 20 μL of 1.55 mol/L NaOH, 250 μL of 0.125 mol/L borate buffer (pH = 9.5) containing 4 mmol/L EDTA and 10 μL of the fluorescent marker, 7-Fluorobenzofurazan-4-sulfonic acid ammonium salt (SBD-F) (10 mg/mL solution in 0.125 mol/L borate buffer), the sample was incubated at 60 °C for 60 minutes and then cooled on ice for subsequent HPLC analysis. The column temperature for HPLC analysis was set at 25 °C. Two buffers were used as the mobile phase: 0.1 mol/L potassium dihydrogen phosphate buffer, pH 2.1 (buffer A); a mixture of buffer A and acetonitrile at the ratio of 1:1 (buffer B). The flow rate was 1.0 mL/min, and the gradient elution procedure was as follows: a 12% buffer B phase lasting for 6 minutes, followed by a 9-minute linear gradient to reach 30% buffer B, subsequently a 1-minute linear gradient to return to 12% buffer B, and a final 4-minute phase at 12% buffer B. The fluorescence detection was performed with excitation and emission wavelengths of 385 nm and 515 nm, respectively.

      To ensure the accuracy of the analysis, a quality control (QC) with a mean concentration of 15.58 (standard deviation, SD, 0.62) μmol/L was used for each 20 samples. The 20 samples would be retested if the corresponding QC result was over the mean ± 2SD limit (i.e., < 14.25 or > 16.81 μmol/L). The intra- and inter-assay coefficient of variations (CV) were < 10%. All the analyses were performed by trained staff who were qualified to perform the assay in a biosafety level II laboratory under yellow light. Hyperhomocysteinemia was defined as the concentration of > 10 μmol/L, according to an international recommendation for pregnant women[24].

    • Medians and interquartile ranges (IQRs) were calculated for Hcy concentration due to its skewed distribution (P value by Kolmogorov-Smirnov D test < 0.001). The adjusted medians and IQRs of Hcy concentration were estimated for each participants using multivariable quantile regression models. Then, the adjusted medians among phases of pregnancy and postpartum or other characteristics were compared using the Mann-Whitney U test, or Kruskal-Wallis test following by Dwass-Steel-Crichtlow-Fligner tests, as appropriate.

      The potential determinants of plasma hyperhomocysteinemia status were further explored using univariable and multivariable logistic regression models. The factors included in the models were phases of pregnancy and postpartum (mid-pregnancy, late pregnancy, and postpartum), geographic region (south, central and north), maternal age (≤ 25, 26 to 30, and 31 to 35 years), parity (nulliparous, and multiparous), ethnicity (Han, and others), education status (middle school or less, high school, and college or higher), annual family income per capita (≤ 30,000, 30,000 to 49,999, 50,000 to 99,999, and ≥ 100,000 Yuan), pre-pregnancy BMI (underweight, normal weight, and overweight/obese). For the postpartum group, models additionally included delivery mode (vaginal delivery, and caesarean delivery) and feeding practice (exclusive breastfeeding, and partial breastfeeding). To ensure the robustness of the result, a sensitivity analysis was performed using the hyperhomocysteinemia defined as ≥ 15.0 μmol/L, a commonly-used threshold in general population.

      All statistical analyses were performed using SAS 9.4 software (SAS Institute, Cary, NC, USA). P values were two-sided, and statistical significance was set at < 0.05.

    • Among the 1,190 participants included in this study, the mean maternal age was 27.3 ± 3.0 years and the mean pre-pregnancy BMI was 20.9 ± 2.9 kg/m2. There were 33.7% (n = 401) of women in mid-pregnancy, 32.6% (n = 388) in late-pregnancy, and 33.7% (n = 401) in postpartum. The proportions of women residing in southern, central and northern regions of China were 32.9% (n = 392), 33.0% (n = 393) and 34.0% (n = 405), respectively. Of the 401 postpartum women, 40.4% (n = 162) underwent a vaginal delivery and 59.6% (n = 239) were exclusive breastfeeding. Detailed characteristics of the participants are shown in Table 1.

      Table 1.  Characteristics of pregnant and postpartum women in China [n (%)]

      Characteristics Phases of pregnancy and postpartum P value
      Total
      (n = 1,190)
      Mid-pregnancy
      (n = 401)
      Late-pregnancy
      (n = 388)
      Postpartum
      (n = 401)
      Geographic region 0.943
      South 392 (32.9) 130 (32.4) 133 (34.3) 129 (32.2)
      Central 393 (33.0) 135 (33.7) 122 (31.4) 136 (33.9)
      North 405 (34.0) 136 (33.9) 133 (34.3) 136 (33.9)
      Age group (years) 0.243
      ≤ 25 328 (27.6) 122 (30.4) 106 (27.3) 100 (24.9)
      26–30 675 (56.7) 223 (55.6) 212 (54.6) 240 (59.9)
      > 30 187 (15.7) 56 (14.0) 70 (18.0) 61 (15.2)
      Pre-pregnancy BMI 0.325
      Underweight 223 (18.7) 73 (18.2) 73 (18.8) 77 (19.2)
      Normal weight 864 (72.6) 288 (71.8) 291 (75.0) 285 (71.1)
      Overweight/obese 103 (8.7) 40 (10.0) 24 (6.2) 39 (9.7)
      Parity 0.360
      Primiparous 992 (83.4) 337 (84.0) 315 (81.2) 340 (84.8)
      Multiparous 198 (16.6) 64 (16.0) 73 (18.8) 61 (15.2)
      Ethnicity 0.047
      Han 1,134 (95.3) 374 (93.3) 376 (96.9) 384 (95.8)
      Others 56 (4.7) 27 (6.7) 12 (3.1) 17 (4.2)
      Education 0.703
      Middle school or less 148 (12.4) 54 (13.5) 52 (13.4) 42 (10.5)
      High school 261 (21.9) 88 (21.9) 83 (21.4) 90 (22.4)
      College or higher 781 (65.6) 259 (64.6) 253 (65.2) 269 (67.1)
      Annual family income per capita (Yuan) < 0.001
      ≤ 30,000 609 (51.2) 184 (45.9) 164 (42.3) 261 (65.1)
      30,000 to < 50,000 324 (27.2) 122 (30.4) 103 (26.5) 99 (24.7)
      50,000 to < 100,000 225 (18.9) 85 (21.2) 104 (26.8) 36 (9.0)
      ≥ 100,000 32 (2.7) 10 (2.5) 17 (4.4) 5 (1.2)
      Postpartum women (n = 401)
      Delivery mode
      Vaginal delivery 239 (59.6)
      Cesarean delivery 162 (40.4)
      Breastfeed
      Partial breastfeeding 162 (40.4)
      Exclusive breastfeeding 239 (59.6)
        Note. BMI, body mass index. “–” denotes that the data were unavailable here.

      The median (IQR) of plasma Hcy concentration was 5.66 (4.62–7.37) μmol/L for overall participants. When stratified by periods of pregnancy and postpartum, the adjusted Hcy concentration was lowest in women at mid-pregnancy (4.75, 4.13–5.54 μmol/L), and increased in women at late-pregnancy (5.72, 4.81–6.85 μmol/L) and postpartum (7.09, 5.65–8.75 μmol/L) (P value for trend of < 0.001) (Table 2). When stratified by regions of residence, the adjusted Hcy concentration was significantly higher in women in northern region (6.08, 4.70–7.82 μmol/L) than those in central (5.56, 5.00–6.60 μmol/L) or southern regions (5.61, 4.80–6.81 μmol/L) (P < 0.001). The trends by phases of pregnancy and postpartum were consistent in each region of residence (Figure 1). Additionally, higher plasma Hcy levels were observed in women who were younger in age, underweight, had Han ethnicity and lower annual family income. Among postpartum women, Hcy concentrations were also higher in those who had a vaginal delivery and those who breastfed partially.

      Table 2.  The crude and adjusted plasma Hcy median (IQRs) concentrations (μmol/L) in pregnant and postpartum women in China

      Characteristics n (%) Overall women 
      (n = 1,190) 
      Pregnant women Postpartum women
      (n = 789) (n = 401)
      Crude
      concentrationa
      Adjusted
      concentrationb
      Adjusted
      concentration
      Adjusted
      concentration
      Phases of pregnancy and postpartum        
      Mid-pregnancy 401 (33.7) 4.68 (4.14, 5.51)1 4.75 (4.13, 5.54)1 4.74 (4.16, 5.56)1
      Late-pregnancy 388 (32.6) 5.75 (4.79, 7.12)2 5.72 (4.81, 6.85)2 5.76 (4.91, 6.96)2
      Postpartum 401 (33.7) 7.16 (5.69, 9.07)3 7.09 (5.65, 8.75)3 c
      Geographic region        
      South 392 (32.9) 5.47 (4.54, 7.10)1 5.61 (4.80, 6.81)1 4.96 (4.57, 5.89)1 6.48 (5.17, 8.90)1
      Central 393 (33.0) 5.52 (4.75, 6.64)1 5.56 (5.00, 6.60)1 4.88 (4.39, 5.49)1 7.13 (5.77, 8.19)2
      North 405 (34.0) 5.98 (4.47, 8.58)2 6.08 (4.70, 7.82)2 5.11 (4.26, 6.79)2 8.07 (6.26, 10.42)3
      Age group (years)        
      ≤ 25 328 (27.6) 5.79 (4.68, 7.76) 5.80 (5.07, 6.92)2 5.09 (4.52, 6.66)3 7.28 (6.37, 9.45)2
      26–30 675 (56.7) 5.61 (4.63, 7.23) 5.63 (4.80, 6.80)1 4.88 (4.33, 6.49)2 7.13 (5.66, 8.88)1
      > 30 187 (15.7) 5.46 (4.45, 7.48) 5.83 (4.63, 7.67)1 5.45 (4.45, 6.25)1 7.41 (5.70, 10.13)
      Pre-pregnancy BMI        
      Underweight 223 (18.7) 5.89 (4.67, 7.53) 5.82 (4.95, 6.91)2 5.13 (4.57, 6.60)3 7.22 (5.91, 9.67)1
      Normal weight 864 (72.6) 5.60 (4.62, 7.23) 5.67 (4.80, 6.80)1 4.97 (4.46, 6.49)2 7.13 (5.66, 8.90)1
      Overweight/obesity 103 (8.7) 5.66 (4.53, 8.10) 6.01 (4.77, 7.90) 4.64 (4.15, 6.22)1 8.20 (6.60, 9.89)2
      Parity        
      Primiparous 992 (83.4) 5.66 (4.65, 7.23) 5.68 (4.88, 6.78) 4.98 (4.44, 6.49) 7.13 (5.73, 8.88)1
      Multiparous 198 (16.6) 5.70 (4.50, 7.87) 5.92 (4.72, 7.33) 5.53 (4.45, 6.55) 7.52 (5.83, 10.85)2
      Ethnicity        
      Han 1,134 (95.3) 5.67 (4.63, 7.41) 5.74 (4.81, 6.90)2 5.07 (4.45, 6.50)2 7.15 (5.72, 9.18)
      Other 56 (4.7) 5.39 (4.39, 6.97) 5.07 (4.77, 6.48)1 4.70 (4.11, 5.81)1 7.05 (6.43, 9.68)
      Education        
      Middle school or less 148 (12.4) 5.55 (4.63, 7.06) 5.66 (4.90, 7.06)1 5.11 (4.53, 6.31) 7.34 (5.78, 11.13)
      High school 261 (21.9) 5.72 (4.66, 7.84) 5.82 (5.00, 6.96)2 4.98 (4.52, 6.68) 7.24 (5.83, 9.28)
      College or higher 781 (65.6) 5.66 (4.57, 7.25) 5.68 (4.78, 6.79)1 4.98 (4.36, 6.49) 7.13 (5.72, 8.90)
      Annual family income per capita (Yuan)        
      ≤ 30,000 609 (51.2) 5.86 (4.67, 7.98)2 6.03 (4.99, 7.82)3 4.97 (4.39, 6.59)2 7.15 (5.70, 9.58)2
      30,000 to < 50,000 324 (27.2) 5.63 (4.68, 7.02)1 5.63 (4.93, 6.63)2 4.97 (4.49, 6.40)2 7.26 (6.13, 8.83)2
      50,000 to < 100,000 225 (18.9) 5.33 (4.48, 6.43)1 5.45 (4.60, 6.60)1 5.56 (4.67, 6.44)3 6.07 (5.34, 8.74)1
      ≥ 100,000 32 (2.7) 4.91 (4.39, 6.06)1 5.15 (4.53, 5.48)1 4.87 (4.34, 5.67)1 7.88 (7.28, 9.16)2
      Delivery mode        
      Vaginal delivery 7.15 (5.83, 8.90)2
      Caesarean delivery 6.81 (5.70, 9.59)1
      Feeding practice  
      Partial breastfeeding 7.24 (5.72, 9.41)2
      Exclusive breastfeeding 6.76 (5.82, 8.96)1
        Note. BMI, body mass index; IQR, interquartile range. aThe crude or adjusted median Hcy concentrations were compared through Mann-Whitney U test or Kruskal-Wallis test followed by Dwass-Steel-Crichtlow-Fligner test for multiple comparisons. The different numerical superscripts indicate significant differences in medians (1 < 2 < 3), P < 0.05. bThe adjusted medians (IQRs) were estimated by multivariate quantile regression model, which adjusted for phases of pregnancy and postpartum, geographic region, maternal age, pre-pregnancy BMI, parity, educational level, ethnicity, educational level and average annual family income; delivery mode and feeding practice were further included in models for postpartum women. c“–” denotes that the data were unavailable here.

      Figure 1.  Plasma Hcy concentrations in mid-pregnant, late pregnant, and postpartum women, by geographic regions in China. Data are presented as box plots; on each box, medians (central mark), interquartile range (bottom and top edges of the box), and minimum/maximum values (whiskers) are shown, n = 1,190.

      Of the 1,190 participants, 106 (8.9%) were categorized as hyperhomocysteinemia. Compared with women at mid-pregnancy, those at late pregnancy (adjusted OR = 5.09, 95% CI 2.18–11.86) and postpartum (adjusted OR = 12.11, 95% CI 5.39–27.21) had a higher risk of hyperhomocysteinemia. Women residing in the northern region had higher risk of hyperhomocysteinemia (adjusted OR = 2.30, 95% CI 1.42–3.72), while women residing in central region had a lower risk (adjusted OR = 0.18, 95% CI 0.08–0.44), as compared with those in southern region. No statistically significant differences were observed in the risks of other maternal characteristics based on the multivariate logistic model. The associations persisted in subgroups stratified by pregnant and postpartum women (Table 3). The sensitivity analysis by employing 15.0 μmol/L as the threshold of hyperhomocysteinemia yielded concordant results (Supplemental Table S1).

      Table 3.  Association of hyperhomocysteinemia with characteristics of pregnant and postpartum women in China

      Characteristics Case of
      hyperhomocysteinemia
      Overall women Pregnant women Postpartum women
      n (%) Crude OR
      (95% CI)
      Adjusted OR
      (95% CI)a
      Adjusted OR
      (95% CI)a
      Adjusted OR
      (95% CI)a
      Phases of pregnancy and postpartum    
      Mid-pregnancy 7 (1.7) Ref Ref b
      Late-pregnancy 33 (8.5) 5.23 (2.29–11.97) 5.09 (2.18–11.86)
      Postpartum 66 (16.5) 11.09 (5.02–24.49) 12.11 (5.39–27.21)
      Geographic region
      South 34 (8.7) Ref Ref Ref Ref
      Central 7 (1.8) 0.19 (0.08–0.44) 0.18 (0.08–0.44) 0.31 (0.08–1.19) 0.12 (0.04–0.38)
      North 65 (16.0) 2.01 (1.30–3.13) 2.30 (1.42–3.72) 2.69 (1.24–5.83) 2.55 (1.33–4.90)
      Age group (years)
      ≤ 25 30 (9.1) 1.18 (0.74–1.89) 0.98 (0.57–1.69) 0.95 (0.42–2.15) 0.84 (0.40–1.77)
      26–30 53 (7.9) Ref Ref Ref Ref
      > 30 23 (12.3) 1.65 (0.98–2.76) 1.15 (0.63–2.09) 1.20 (0.49–2.95) 1.30 (0.57–2.96)
      Pre-pregnancy BMI
      Underweight 18 (8.1) 0.88 (0.52–1.51) 0.75 (0.42–1.32) 0.77 (0.30–1.93) 0.75 (0.36–1.56)
      Normal weight 78 (9.0) Ref Ref Ref Ref
      Overweight/obesity 10 (9.7) 1.08 (0.54–2.17) 1.02 (0.47–2.21) 0.68 (0.19–2.36) 1.18 (0.42–3.30)
      Parity
      Primiparous 74 (7.5) Ref Ref Ref Ref
      Multiparous 32 (16.2) 2.39 (1.53–3.74) 1.68 (0.94–3.00) 1.50 (0.63–3.59) 1.93 (0.88–4.25)
      Ethnicity
      Han 101 (8.9) Ref Ref Ref Ref
      Other 5 (8.9) 1.00 (0.39–2.57) 0.89 (0.32–2.46) 0.96 (0.27–3.39) 0.59 (0.12–2.96)
      Education
      Middle school or less 21 (14.2) Ref Ref Ref Ref
      High school 26 (10.0) 0.67 (0.36–1.24) 0.77 (0.38–1.53) 0.95 (0.34–2.63) 0.57 (0.21–1.50)
      College or higher 59 (7.6) 0.49 (0.29–0.84) 0.54 (0.28–1.04) 0.64 (0.25–1.65) 0.39 (0.15–1.02)
      Annual family income per capita (Yuan)
      ≤ 30,000 72 (11.8) Ref Ref Ref Ref
      30,000 to < 50,000 22 (6.8) 0.54 (0.33–0.89) 0.70 (0.41–1.19) 0.82 (0.37–1.79) 0.59 (0.28–1.24)
      50,000 to < 100,000 11 (4.9) 0.38 (0.20–0.74) 0.53 (0.26–1.08) 0.49 (0.18–1.34) 0.68 (0.25–1.85)
      ≥ 100,000 1 (3.1) 0.24 (0.03–1.79) 0.35 (0.04–2.74) 0.66 (0.08–5.33) ×c
      Delivery mode
      Vaginal delivery Ref
      Caesarean delivery 0.70 (0.38–1.30)
      Feeding Practice
      Partial breastfeeding Ref
      Exclusive breastfeeding 1.32 (0.71–2.45)
        Note. 95% CI, 95% confidence interval; OR, odds ratio; Ref, reference; BMI, body mass index. aAdjusted ORs and 95% CIs were estimated by multivariable logistic regression models by including phases of pregnancy and postpartum, geographic region, maternal age, pre–pregnancy BMI, parity, ethnicity, education level and income; delivery mode and feeding practice were further included in models for postpartum women. b“–” denotes that the data were unavailable here. c“×” denotes that it was not applicable since no case of hyperhomocysteinemia in this subgroup of postpartum women.
    • From this large cross-sectional study among Chinese women at pregnancy and postpartum, we observed that the plasma Hcy concentrations were increased from mid-pregnancy to late-pregnancy and postpartum. We also found a higher Hcy level in women residing in northern region, having younger age or lower economic status, and in postpartum women underwent vaginal delivery or partially breastfeeding. Consistently, hyperhomocysteinemia was more likely occurred in women at late pregnancy and postpartum as compared with those at mid-pregnancy, and in women residing in the northern region as compared with those in southern region.

      Our study found that women at mid-pregnancy had a lower Hcy concentration (4.75 μmol/L) compared to women at late-pregnancy (5.72 μmol/L), independent of other maternal characteristics, indicating an upward trend of maternal Hcy concentration from mid-pregnancy to late-pregnancy. This pattern was consistently observed in pregnant women from western countries, such as Canada (4.3 μmol/L in mid-pregnancy and 5.6 μmol/L in late-pregnancy)[11], Spain (4.2 μmol/L and 4.4 μmol/L)[12], and Denmark (6.1 μmol/L and 6.6 μmol/L)[15], as well as in those from other Asian countries, such as Japan (5.0 μmol/L and 5.9 μmol/L)[25]. A previous study conducted in women in Changsha city of China also showed the similar result (8.3 μmol/L and 9.5 μmol/L)[26]. However, it’s worth noting that the Hcy concentration values in the Changsha study were notably higher than those in our study and other previous studies. This discrepancy may be attributed to the different Hcy assay methods used. The Changsha study employed the enzyme cycling method, which tends to yield higher values compared to the HPLC method[27].

      To our knowledge, this is the first study to reveal a significant increase in Hcy concentration from late-pregnancy to postpartum among Chinese women. Our data showed that the Hcy concentration reached 7.09 μmol/L for women at 42 ± 7 days postpartum, significantly higher than that for women at late-pregnancy. Only three studies to date, respectively conducted in Denmark, Brazil and Seychelles, have reported changes in Hcy concentration from late-pregnancy to postpartum. Remarkably, two of them revealed a consistent pattern of findings with the current study: in the Denmark study, Hcy concentrations increased from a median of 7.7 μmol/L at 39 weeks of gestation to 10.8 μmol/L at 8 weeks postpartum[15]; and in the Brazil study, from 5.0 μmol/L at late-pregnancy to 7.0 μmol/L 28 to 50 days postpartum[16].

      The upward trend of Hcy concentrations from mid-pregnancy to late-pregnancy and postpartum was possibly attributed to a decrease in maternal folate level, as shown in our previous study[28]. By using folate as an enzyme co-factor or 5-methyltetrahydrofolate as the methyl donor, the Hcy can be trans-sulfuration or remethylated to methionine[29]. When plasma folate was deficient, Hcy cannot be efficiently recycled and therefore accumulates in the blood. Thus, the low folate status could hinder Hcy metabolism, leading to the increasing of plasma Hcy concentration. Previous population-based studies also demonstrated the inverse association between plasma folate status and Hcy level[30-32]. Additionally, an alternative mechanism for the upward trend in Hcy concentration from mid-pregnancy to postpartum might be endocrine-based[12]. Pregnancy and postpartum involve complex changes in female hormones, many of which have been reported to affect Hcy concentrations[33,34].

      Our study showed a geographic variation in Hcy status of pregnant and postpartum women, with the highest Hcy concentration and a higher risk of hyperhomocysteinemia in women residing in the northern than in the central and southern regions of China. The geographic variation has been observed in general population in China. A meta-analysis consisting 60,754 Chinese subjects consistently showed the highest prevalence of hyperhomocysteinemia in northern and the lowest in southern region[35]. The geographic variation could be partly due to the distinct differences in dietary patterns across regions. A national survey in China showed that the dietary folate intake for women of reproductive age was significantly lower in northern versus southern region[36]. A lower folate intake was relevant to a deficient plasma folate status and consequently, as mentioned above, lead to elevated Hcy levels. Gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) 677C–>T could contribute to the geographic variation in Hcy status. Studies have reported that women of reproductive age in northern versus southern China had higher proportion of MTHFR 677 TT genotype[37,38], which has been proved to be associated with higher risk of hyperhomocysteinemia[39]. Our study also showed higher Hcy levels in women with younger age or lower economic status, consistent with previous studies[40].

      This study has several strengths. To our best knowledge, this is the first one to comprehensively report patterns of plasma Hcy levels for pregnant and postpartum women in China. A wide range of potential determinants such as geographic region and maternal social-demographic characteristics were analyzed in this study. Hcy concentration was determined using HPLC method, an internationally standardized and accurate assay[41], making direct international comparison possible.

      This study also has limitations. Firstly, the participants were general healthy women residing in urban city, restricting the extrapolation of our findings. Secondly, our study was a cross-sectional study in different women at mid-pregnancy, late-pregnancy, and postpartum, preventing us from directly investigating the temporal trends of Hcy levels in a cohort of women. The trends of Hcy concentrations across mid-pregnancy, late-pregnancy, and postpartum were investigated by comparison of adjusted medians, effectively eliminating the potential bias related to geographic region or maternal characteristics. Thirdly, the samples have been stored for nearly nine years before they were assayed, potentially leading to bias. However, the samples were kept at –80 °C until analysis, so the bias should be minimized[42]. Fourthly, the sample size might be limited, especially in subgroup analysis, which could affect the generalizability of our results. Finally, we failed to include data on folate and vitamin B12 status of the participants in our analysis, which may influence the association with maternal social-demographic characteristics.

    • In summary, this large cross-sectional study involving Chinese pregnant and postpartum women showed that maternal plasma Hcy levels increased markedly from mid-pregnancy to late-pregnancy and postpartum, suggesting an upward trend of Hcy levels from mid-pregnancy to postpartum. Maternal Hcy levels were also varied by geographic regions and maternal characteristics such as maternal age and economic status. Additionally, delivery mode and breastfeeding might be influencing factors for postpartum women. These findings highlighted the necessity to develop systematic monitoring programs for women through pregnancy to postpartum to lower levels of Hcy, even in the post folic acid fortification era. Prospective studies with longitudinal design are warranted to confirm our findings. Furthermore, future investigations should delve into the interrelationships among Hcy, folate, Vitamin B12, and genetic mutations in pregnant and postpartum women.

    • Table S1.  Association of hyperhomocysteinemia (defined as > 15.0 μmol/L) with characteristics of pregnant and postpartum women in China

      Characteristics Case of hyperhomocysteinemia
      (Defined as > 15.0 μmol/L)
      Overall women
      n (%) Crude OR (95% CI) Adjusted OR (95% CI)a
      Phases of pregnancy and postpartum  
      Mid–pregnancy 4 (1.0) Ref Ref
      Late–pregnancy 6 (1.5) 1.56 (0.44–5.57) 1.28 (0.35–4.74)
      Postpartum 25 (6.2) 6.60 (2.28–19.14) 6.46 (2.17–19.18)
      Geographic region
      South 8 (2.0) Ref Ref
      Central 2 (0.5) 0.25 (0.05–1.16) 0.22 (0.04–1.11)
      North 25 (6.2) 3.16 (1.41–7.09) 3.56 (1.52–8.38)
      Age group
      ≤ 25 11 (3.4) 1.64 (0.74–3.65) 1.42 (0.58–3.49)
      26–30 14 (2.1) Ref Ref
      > 30 10 (5.3) 2.67 (1.17–6.11) 2.17 (0.86–5.48)
      Pre-pregnancy BMI
      Underweight 6 (2.7) 1.01 (0.41–2.51) 0.84 (0.32–2.20)
      Normal weight 23 (2.7) Ref Ref
      Overweight/obesity 6 (5.8) 2.26 (0.90–5.69) 1.95 (0.71–5.34)
      Parity
      Primiparous 24 (2.4) Ref Ref
      Multiparous 11 (5.6) 2.37 (1.14–4.93) 1.60 (0.62–4.12)
      Ethnicity
      Han 35 (3.1) Ref Ref
      Other 0 (0.0) b b
      Education
      Middle school or less 7 (4.7) Ref Ref
      High school 9 (3.4) 0.67 (0.36–1.24) 0.81 (0.26–2.49)
      College or higher 19 (2.4) 0.50 (0.21–1.22) 0.61 (0.21–1.79)
      Annual family income per capita (Yuan)
      ≤ 30,000 24 (3.9) Ref Ref
      30,000 to < 50,000 9 (2.8) 0.70 (0.32–1.52) 0.88 (0.38–2.03)
      50,000 to < 100,000 2 (0.9) 0.22 (0.05–0.93) 0.37 (0.08–1.64)
      ≥ 100,000 0 (0.0) ×c ×c
        Note. 95% CI, 95% confidence interval; BMI, body mass index; OR, odds ratio; Ref, reference. aAdjusted ORs and 95% CIs were estimated by multivariable logistic regression models by including phases of pregnancy and postpartum, geographic region, maternal age, pre-pregnancy BMI, parity, ethnicity, education level and income; delivery mode and feeding practice were further included in models for postpartum women. b“–” denotes that the data were unavailable here. c“×” denotes that it was not applicable since no case of hyperhomocysteinemia in the specific groups.
参考文献 (42)

目录

    /

    返回文章
    返回